You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Unfunded Intravenous (IV) Cancer Drugs

A difficult issue is what to do when patients seek out very expensive cancer drugs which have not been approved for funding. Cancer Care Ontario is working with different levels of government to strengthen publicly funded programs for cancer drugs, and to also look at the level of medical benefit, appropriateness and cost-effectiveness of different drugs.

Provincial Working Group Recommendations

The Provincial Working Group on the Delivery of Oncology Medications for Private Payment in Ontario Hospitals have developed recommendations for the Ministry of Health and Long-Term Care (MOHLTC) for the provision of unfunded IV cancer drugs.

These documents are available as guidance to hospitals. They do not represent ministry or Cancer Care Ontario policy:

Related Resources